| 0.608 Data as of May 17 |  +0.028 / +4.83%Today’s Change | 0.49 Today|||52-Week Range 3.21 | -1.94% Year-to-Date |
| Previous close | 0.58 |
| Today’s open | 0.58 |
| Day’s range | 0.58 - 0.62 |
| Volume | 623,802 |
| Average volume (3 months) | 789,617 |
| Market cap | $92.8M |
| Dividend yield | -- |
| Earnings growth (last year) | +59.61% |
| Earnings growth (this year) | +76.21% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| CPIXCumberland Pharmaceu... | -0.01 | -0.20% |
| DRRXDURECT Corp | -0.09 | -9.08% |
| NNVCNanoViricides Inc | -0.02 | -3.49% |
| APRIApricus Biosciences ... | +0.22 | +7.28% |
| Last reporting date | May 14, 2013 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$59.4M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Paul F. Truex, MBA |
CFO, Chief Business Officer & VP-Administration Christopher P. Lowe, MBA |
Corporate headquarters Hayward, California |
.
